| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $101K | +9.3% | -69.3% |
| Cost of Revenue | $68K | +10.8% | -65.5% |
| Gross Profit | $34K | +6.5% | -75.0% |
| R&D Expense | $110K | +514.1% | — |
| SG&A Expense | $603K | +62.5% | +44.1% |
| Operating Income | -$4.2M | -118.8% | -18.8% |
| Net Income | -$5.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $40K | +4.8% | -81.8% |
| Inventory | $494K | +61.1% | +31.5% |
| Current Assets | $8.4M | +532.4% | +151.4% |
| Total Assets | $9.7M | +173.9% | +77.0% |
| Current Liabilities | $1.1M | +36.8% | +5.6% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.5M | — | — |
| Capital Expenditures | $26K | — | — |
| Investing Cash Flow | -$234K | — | — |
| Financing Cash Flow | $9.4M | — | — |
| Free Cash Flow | -$3.6M | — | — |
| -35.9% |
| EPS (Basic) | -$0.29 | -123.1% | +14.7% |
| EPS (Diluted) | -$0.29 | -123.1% | +14.7% |
| $146K |
| +0.0% |
| +0.0% |
| Total Liabilities | $1.3M | +29.2% | +1.1% |
| Stockholders' Equity | $8.4M | +228.7% | +99.3% |